Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
about
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder.Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report.Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world.The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy.Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy.
P2860
Q35653741-041703D7-14BA-4CE7-86E3-166E7BA1A43DQ36103157-BB936620-9EE3-4DDF-B0DC-FE4CE3314F2AQ36947812-1A9742D9-2D0C-4C58-AA16-1EB387475EB1Q40447356-4970BC70-4843-40EE-8FD0-4253C49412A0Q41620841-0000C028-BB91-4759-8AC7-AA7DA564B664Q47102176-D6F313DE-81D9-44AE-9B51-5EFD3D66EAC6Q51206876-4D7CC6CF-DE3E-4AB4-8F1A-75408EA3E3D9
P2860
Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic and predictive fact ...... ial cancer: where do we stand?
@en
type
label
Prognostic and predictive fact ...... ial cancer: where do we stand?
@en
prefLabel
Prognostic and predictive fact ...... ial cancer: where do we stand?
@en
P2093
P2860
P50
P356
P1433
P1476
Prognostic and predictive fact ...... ial cancer: where do we stand?
@en
P2093
Alessandra Modena
Andrea Ardizzoni
Anita Rimanti
Annalisa Gilli
Chiara Ciccarese
Daniele Zanoni
Francesca Maines
Matteo Brunelli
P2860
P304
P356
10.2217/FON.14.172
P407
P577
2015-01-01T00:00:00Z